Background:
Carotid artery restenosis after carotid endarterectomy (CEA) or carotid artery stenting (CAS) will occur in 3%-30% of cases. Restenosis can lead to more frequent clinical and imaging monitoring and the potential for reoperation. We sought to define the demographic, clinical, and radiographic characteristics that influence the restenosis risk after carotid revascularization.
Methods:
The present study was performed in accordance with the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines. A random effects model meta-analysis of hazard ratios (HRs) was conducted.
Results:
Eighteen studies with 17,106 patients were included. Diabetes (HR, 1.68; 95% confidence interval [CI], 1.00-2.83; I, 76.7%), dyslipidemia (HR, 1.77; 95% CI, 1.08-2.91; I, 22.5%), female gender (HR, 1.50; 95% CI, 1.14-1.98, I, 0%), chronic kidney disease (HR, 4.15; 95% CI, 1.69-10.19; I, 44.5%), hypertension (HR, 1.99; 95% CI, 1.07-3.72; I, 68%), smoking (HR, 1.65; 95% CI, 1.15-2.37; I, 54.3%), and pretreatment stenosis >70% (HR, 1.04; 95% CI, 1.0-1.08; I, 0%) showed a statistically significant increase in restenosis risk after carotid revascularization. Subgroup analyses of CEA and CAS showed that female gender and smoking status were significantly associated with recurrent stenosis after CEA but not after CAS. In contrast, hypertension was associated with restenosis after CAS but not after CEA. Patch endarterectomy (HR, 0.33; 95% CI, 0.22-0.50; I, 0%) and symptomatic status at presentation in the CAS group (HR, 0.61; 95% CI, 0.41-0.90; I, 0%) were associated with a decreased risk of restenosis. Antiplatelet use and coronary artery disease were not associated with restenosis risk.
Conclusions:
Diabetes, dyslipidemia, female gender, renal failure, hypertension, and smoking were associated with an increased risk of restenosis, and patch endarterectomy and symptomatic status at presentation were associated with a decreased risk of carotid restenosis. Both female gender and current smoking status were only associated with recurrent stenosis after CEA, and hypertension was only associated with restenosis after CAS.
Citing Articles
Advancements in the Treatment of Atherosclerosis: From Conventional Therapies to Cutting-Edge Innovations.
Liu Y, Lu K, Zhang R, Hu D, Yang Z, Zeng J
ACS Pharmacol Transl Sci. 2024; 7(12):3804-3826.
PMID: 39698263
PMC: 11651175.
DOI: 10.1021/acsptsci.4c00574.
Risk factors of in-stent restenosis after carotid angioplasty and stenting: long-term follow-up study.
Park S, Kim B, Choi H, Chang D, Woo H, Heo S
Front Neurol. 2024; 15:1411045.
PMID: 39175764
PMC: 11340531.
DOI: 10.3389/fneur.2024.1411045.
Subclavian-Carotid Bypass as a Solution to Recurrent Carotid Artery Stenosis Post Endarterectomy and Transfemoral Stenting.
Balakrishnan P, Anderson J, Arcand C, Krantz M, Kitchen J
Cureus. 2024; 16(6):e63087.
PMID: 39055438
PMC: 11270155.
DOI: 10.7759/cureus.63087.
Associations of genetic markers of diabetes mellitus with carotid atherosclerosis: a community-based case-control study.
Wu T, Chou C, Cheng C, Lu S, Wu Y, Wang L
Cardiovasc Diabetol. 2023; 22(1):51.
PMID: 36894991
PMC: 9999522.
DOI: 10.1186/s12933-023-01787-7.
Long-term outcomes of carotid artery stenting in patients with carotid artery stenosis: A single-center 14-year retrospective analysis.
Kang B, Mann Yoon S, Oh J, Oh H, Ahn J, Yong Yun G
J Cerebrovasc Endovasc Neurosurg. 2023; 25(2):160-174.
PMID: 36718046
PMC: 10318231.
DOI: 10.7461/jcen.2023.E2022.07.007.
Carotid Plaque Features and Inflammatory Biomarkers as Predictors of Restenosis and Mortality Following Carotid Endarterectomy.
Niculescu R, Russu E, Arbanasi E, Kaller R, Arbanasi E, Melinte R
Int J Environ Res Public Health. 2022; 19(21).
PMID: 36360814
PMC: 9654888.
DOI: 10.3390/ijerph192113934.
Protein Tyrosine Phosphatase 1B Deficiency in Vascular Smooth Muscle Cells Promotes Perivascular Fibrosis following Arterial Injury.
Gogiraju R, Gachkar S, Velmeden D, Bochenek M, Zifkos K, Hubert A
Thromb Haemost. 2022; 122(10):1814-1826.
PMID: 36075234
PMC: 9512587.
DOI: 10.1055/s-0042-1755329.
Sex differences in arterial identity correlate with neointimal hyperplasia after balloon injury.
Gao M, Gao X, Taniguchi R, Brahmandam A, Matsubara Y, Liu J
Mol Biol Rep. 2022; 49(9):8301-8315.
PMID: 35715609
PMC: 9463237.
DOI: 10.1007/s11033-022-07644-2.
Carotid endarterectomy with stent removal for recurring in-stent restenosis: A case report and literature review.
Takahashi Y, Higashida T, Uchida T, Watanabe S, Kanazawa R
Surg Neurol Int. 2022; 13:192.
PMID: 35673638
PMC: 9168307.
DOI: 10.25259/SNI_1222_2021.
Diabetes and restenosis.
Wilson S, Mone P, Kansakar U, Jankauskas S, Donkor K, Adebayo A
Cardiovasc Diabetol. 2022; 21(1):23.
PMID: 35164744
PMC: 8845371.
DOI: 10.1186/s12933-022-01460-5.
The role of self-expanding vascular stent in superior vena cava syndrome for advanced tumours.
Irace L, Martinelli O, Gattuso R, Mingoli A, Fiori E, Alunno A
Ann R Coll Surg Engl. 2021; 103(4):296-301.
PMID: 33682470
PMC: 10335251.
DOI: 10.1308/rcsann.2020.7127.
Diabetes and carotid artery disease: a narrative review.
Katsiki N, Mikhailidis D
Ann Transl Med. 2020; 8(19):1280.
PMID: 33178812
PMC: 7607073.
DOI: 10.21037/atm.2019.12.153.
The management of carotid restenosis: a comprehensive review.
Stilo F, Montelione N, Calandrelli R, Distefano M, Spinelli F, Di Lazzaro V
Ann Transl Med. 2020; 8(19):1272.
PMID: 33178804
PMC: 7607074.
DOI: 10.21037/atm-20-963.
Carotid Artery Angioplasty and Stenting for Carotid Stenosis: A Single-Center Experience from Saudi Arabia.
Algahtani H, Shirah B, Alghamdi A, Subahi A, Alqahtani S, Alshamy A
Neurointervention. 2020; 15(3):133-139.
PMID: 32894903
PMC: 7608497.
DOI: 10.5469/neuroint.2020.00052.
Prevalence and risk factors of postoperative delirium after spinal surgery: a meta-analysis.
Gao H, Ma H, Li Y, Yin C, Li Z
J Orthop Surg Res. 2020; 15(1):138.
PMID: 32272939
PMC: 7146882.
DOI: 10.1186/s13018-020-01651-4.
Long-term Outcomes of Carotid Artery Stenting: A Single-center Experience.
Fuse Y, Kojima T, Shintai K, Seki Y
Neurol Med Chir (Tokyo). 2020; 60(3):121-125.
PMID: 31902874
PMC: 7073700.
DOI: 10.2176/nmc.oa.2019-0192.
Correlation of pre-operative circulating inflammatory cytokines with restenosis and rapid angiographic stenotic progression risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents.
Sun J, Yu H, Liu H, Pu D, Gao J, Jin X
J Clin Lab Anal. 2019; 34(3):e23108.
PMID: 31729103
PMC: 7083400.
DOI: 10.1002/jcla.23108.